{"id":"W4393301802","doi":"10.1016/s1470-2045(24)00100-1","title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Chemoradiotherapy; Placebo; Regimen; Head and neck squamous-cell carcinoma; Clinical endpoint; Internal medicine; Radiation therapy; Oncology; Head and neck cancer; Clinical trial; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083998,0.0004330419,0.002041184,0.0001110902,0.0001232307,0.00002780047,0.0003166218,0.0001870447,0.0000571199],"category_scores_gemma":[0.00005103419,0.0002389659,0.0001811941,0.0004106752,0.0005802596,0.00007200316,0.00007932018,0.000695913,0.00000393011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009713317,"about_ca_system_score_gemma":0.001354708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001329885,"about_ca_topic_score_gemma":0.0002955497,"domain_scores_codex":[0.9974481,0.0002676118,0.000656266,0.0005577595,0.0004436553,0.0006266119],"domain_scores_gemma":[0.9982668,0.0006720683,0.0002586564,0.0005271107,0.0001283279,0.0001470081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9628671,0.0008503727,0.001054183,0.0004469219,0.0001735472,0.0000457766,0.004171024,0.00007886157,0.0002223845,0.0001009766,0.001040117,0.02894869],"study_design_scores_gemma":[0.9656758,0.0155264,0.001503146,0.0002635838,0.0002288585,0.00002178237,0.0001890271,0.001199461,0.001229958,0.000006087334,0.01388233,0.000273549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763991,0.01148192,0.00005685571,0.002685214,0.002262171,0.005615694,0.00005113435,0.0000588378,0.001389088],"genre_scores_gemma":[0.9969535,0.0009048357,0.00005677183,0.0005484708,0.0007433008,0.0005684664,0.0000240963,0.00005902831,0.0001415239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02867515,"threshold_uncertainty_score":0.9744748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0493403772247069,"score_gpt":0.3628449011368754,"score_spread":0.3135045239121685,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}